Upload
hoangkhanh
View
217
Download
1
Embed Size (px)
Citation preview
Function: antiradical, antioxidant, vasoconstrictor
Renewable botanical origin: Lannea microcarpa fruit extract
Geographic origin: Intertropical West Africa (Burkina Faso)
Cosmos, Ecocert standard availability
Available forms: Powder- Sensiteam Be- INCI: Bentonite & Lannea microcarpa fruit extract
Liquid - Sensiteam Et- INCI: Alcohol& Lannea microcarpa fruit extract
000
Identity card
an amazing Skin Protector Active Ingredient from African wild grape extract
EPHYLA SAS Centre De Recherche Yves Coppens, UBS - Campus de Tohannic BP 573 – 56000 Vannes Tel : 09.81.61.62.79 – Fax : 09.81.70.35.59 Email : [email protected]
In vivo analysis
1. Antiradical effect: DPPH Test
2. Antioxidant effect:
Results:
Lipoperoxidation particularly affects the lipid bilayers of cell membranes. Limit this stress contributes to maintain cell membranes integrity.
Sensiteam® reinforces cells membrane integrity at the basal level and ensures an anti-lipoperoxidation effect. 3. Vasoconstrictor effect
Efficiency of Sensiteam® at 1% on skin problem with a panel of 24 Canadians subjects versus placebo
In vitro analysis
Results:
Sensiteam® at 0,2 % : inhibition of 8 % of radical activity Sensiteam® at 2 % : inhibition of 100 % of radical activity
Because of the cellular senescence inhibition, SENSITEAM® extends
healthy life span of skin cells.
71,2 73,2
181,5
0
50
100
150
200
% E
ndot
hélin
s ne
oynt
hesi
s
Stimulation of endothelins neosynthesis-In vitro analysis of human endothelial cells
% SENSITEAM
50
55
60
65
70
75
80
85
J2 J7 J10
Num
ber o
f pos
itive
opi
nion
s (%
)
Fewer imperfections
SENSITEAM
Placebo
From 7 days, a high rate of satisfaction is expressed. The rate differs significantly from placebo effect.
Results:
By stimulating endothelins neosynthesis, Sensiteam® increases cellular regeneration of skin microvessels. Skin vascularization is improved and its unsightly disorders are cleared.
0,004% 0,01% 0,02%
-9 -64
-100 -200
-100
0
% T
BA
RS
% Sensiteam
Decrease in the basal emergence of TBARS - In vitro in a human dermal fibroblast model 0,002 % 0,01 % 0,02 %